Abstract
Drug resistance is a major factor that limits the effectiveness of cancer chemotherapy, and there is considerable evidence to suggest a genetic basis for many drug-resistant phenotypes. A major drawback to many of the conventional approaches used to investigate drug-resistance mechanisms is that some prior information or guesswork on the changes that have occurred is required, thus necessitating separate reagents to screen each possible change. When analyzing genetic changes for example, screening is limited to the use of gene or region specific probes as in Southern blot or microsatellite analysis. Recently, the molecular cytogenetic techniques of reverse in situ hybridization (REVISH), and its more advanced relative, comparative genomic hybridization (CGH), have been developed for the rapid global detection and mapping of genetic imbalances in tumor genomes (1–7). In REVISH, genomic DNA from the tumor is used as a complex probe and hybridized to normal metaphase chromosomes (6). Genomic sequences amplified in the tumor are then detected as an increased intensity of signal at the normal chromosomal position from which the amplified sequences are derived (1,6,7). For more accurate analysis of both loss and gain of genetic material, CGH is required; however, CGH involves complex fluorescence-comparison techniques and expert knowledge of chromosome identification (2). However, both REVISH and CGH are ideal methods to detect genetic changes associated with the acquisition of drug resistance in tumors (6,8).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Joos, S., Scherthan, H., Speicher, M. R., Schlegel, J., Cremer, T., and Lichter, P. (1993) Detection of amplified DNA sequences by reverse chromosome painting using genomic tumor DNA as probe. Human Genet. 90, 584–589.
Kallioniemi, O.-P., Kallioniemi, A., Sudar, D., Rutovitz, D., Gray, J. W., Waldman, F., and Pinkel, D. (1993) Comparative genomic hybridisation: a rapid new method for detecting and mapping DNA amplification in tumors. Seminars Cancer Biol. 4, 41–46.
Kallioniemi, A., Kallioniemi, O.-P., Sudar, D., Rutovitz, D., Gray, J. W., Waldman, F., and Pinkel, D. (1992) Comparative genomic hybridisation for molecular cytogenetic analysis of solid tumors. Science 258, 818–821.
Houldsworth, J. and Chaganti, R. S. K. (1994) Comparative genomic hybridization: an overview. Am. J. Pathol. 145, 1253–1260.
Van Ommen, G. J. B., Breuning, M. H., and Raap, A. K. (1995) FISH in genome research and molecular diagnostics. Curr. Opin. Genet. Dev. 5, 304–308.
Hoare, S., Freeman, C., Coutts, J., Varley, J., James, L., and Keith, W. (1997) Identification of genetic changes associated with drug resistance by reverse in situ hybridization. Br. J. Cancer 75, 275–82.
Lichter, P., Bentz, M., and Joos, S. (1995) Detection of chromosomal aberrations by means of molecular cytogenetics: painting of chromosomes and chromosomal subregions and comparative genomic hybridization. Methods Enzymol. 254, 334–359.
Wasenius, V. M., Jekunen, A., Monni, O., Joensuu, H., Aebi, S., Howell, S. B. and Knuutila, S. (1997) Comparative genomic hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cells. Genes Chromosomes Cancer 18, 286–291.
Lichter, P., Tang, C. C., Call, K., Hermanson, G., Evans, G. A., Housman, D., and Ward, D. C. (1990) High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science 247, 64–69.
McLeod, H. L. and Keith, W. N. (1996) variation in topoisomerase I gene copy number as a mechanism for intrinsic drug sensitivity. Br. J. Cancer 74, 508–512.
Bray-Ward, P., Menninger, J., Lieman, J., Desai, T., Mokady, N., Banks, A., and Ward, D. C. (1996) Integration of the cytogenetic, genetic, and physical maps of the human genome by FISH mapping of CEPH YAC clones. Genomics 32, 1–14.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Humana Press Inc.
About this protocol
Cite this protocol
Keith, W.N. (1999). Genetic Analysis of Drug Resistance by Reverse In Situ Hybridization. In: Brown, R., Böger-Brown, U. (eds) Cytotoxic Drug Resistance Mechanisms. Methods in Molecular Medicine™, vol 28. Humana Press. https://doi.org/10.1385/1-59259-687-8:225
Download citation
DOI: https://doi.org/10.1385/1-59259-687-8:225
Publisher Name: Humana Press
Print ISBN: 978-0-89603-603-1
Online ISBN: 978-1-59259-687-4
eBook Packages: Springer Protocols